MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Allergic Rhinitis and Sensitization
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,219 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,219 works in the cohort · of 4,299,418page 12 of 25

Labels cover 3 of 1,219 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,219 of 1,219 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

afffundunlabeled
Allergen Binding to Human Peripheral Leukocytes
T. Hubscher, A.H. Eisen
2009· article· en· International Archives of Allergy and Applied Immunology· Medicine
distilled prediction:candidate · noneconsensus · none
10
citations
afffundno abstractunlabeled
Peptide and Recombinant Immunotherapy
Mark Larché
2011· article· en· Immunology and Allergy Clinics of North America· Medicine
distilled prediction:candidate · noneconsensus · none
10
citations
venueno affno abstractunlabeled
Allergen Immunotherapy Efficacy in Rhinitis and Asthma
Hans‐Jørgen Malling
2004· article· en· Allergy & Clinical Immunology International - Journal of the World Allergy Organization· Medicine
distilled prediction:candidate · noneconsensus · none
10
citations
venueno affno abstractunlabeled
Functional Properties of ClonedAllergens from Dust Mite, Cockroach, and Cat
Anna Pomés, Alisa Smith, Christophe Grégoire, Lisa D. Vailes, L. Karla Arruda, Martin D. Chapman
2001· article· en· Allergy & Clinical Immunology International - Journal of the World Allergy Organization· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
9
citations
affunlabeled
Desloratadine for allergic rhinitis
Jeffrey Wilken, Adrian Daly, Cynthia Sullivan, Harold Kim
2006· article· en· Expert Review of Clinical Immunology· Medicine
distilled prediction:candidate · noneconsensus · none
9
citations
venueno affno abstractunlabeled
Frequency of Fungi in Homes of Pediatric Allergy Patients
Charles S. Barnes, Chitra Dinakar, Mamta Reddy, Jay M. Portnoy
2006· article· en· Allergy & Clinical Immunology International - Journal of the World Allergy Organization· Medicine
distilled prediction:candidate · noneconsensus · none
9
citations
affno abstractunlabeled
Peptide Immunotherapy; Short but Long Lasting?
Elizabeth Simms, Ijlal Syed, Christopher D. Rudulier, Mark Larché
2015· article· en· Current Treatment Options in Allergy· Medicine
distilled prediction:candidate · noneconsensus · none
9
citations
affvenueaboutunlabeled
Focused allergic rhinitis practice parameter for Canada
Anne K. Ellis, Victoria E. Cook, Paul K. Keith, Sean R. Mace, William Moote, Andrew O’Keefe +4 more
2024· article· en· Allergy Asthma and Clinical Immunology· Medicine
distilled prediction:candidate · noneconsensus · none
9
citations

How this was built: Screen · Findings · About